Antibody Therapeutics Patients First!

공지사항

보도자료

홍보영상

공지사항


번호 제목 작성자 작성일 조회
  파멥신, 기술파트너링 및 학회 참석 리스트_11~16년   관리자   2019-01-14   288  
64   PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine is invited to give a lecture at DGIST Brain and Cognitive Sciences   관리자   2019-02-07   139  
63   PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine is invited to present at the 2nd Korean Immuno-Oncology Symposium 2019 March 8th,   관리자   2019-02-07   95  
62   PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine is invited to host CEO Roundtable at WuXi Healthcare Forum 2019 March 5-6,   관리자   2019-02-07   87  
61   PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine is invited to attend to JP Morgan's Korea Conference 2019 (February 21-22).   관리자   2019-02-07   201  
60   PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine was invited to attend as MAB working group expert for EDQM MAB Experts meeting   관리자   2019-02-07   81  
59   PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine, Dr. Weon Sup Lee, Head of R&D Center, Dr. Sung Woo Kim, Head of BD were invited by JP Morgan Healthcare Confe   관리자   2019-02-07   93  
58   파멥신, 2018 제12회 하반기 대한민국 우수특허 大賞   관리자   2019-01-04   313  
57   Quarterly Magazine KoNECT 14호(2018.12)_Interview of Dr. Jin-San Yoo   관리자   2019-01-04   244  
56   PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Weon Sup Lee, Head of R&D center and PharmAbcine R&D staffs have attended and presented their R&D progress of both TTAC-0001 (Tanibirumab) and PMC-309 projects funded by KDDF   관리자   2018-09-10   3,537